Trial intelligence / Profile preview

Vaginal 17β-Estradiol for Storage LUTS in Postmenopausal Women

NCT06508944Phase 4Completed

Sponsor
Mahidol University
Start
Apr 2024
Primary completion
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Femiest in lower urinary tract symptoms (LUTS), sponsored by Mahidol University. Started Apr 2024; status: completed.

02

Drugs

Femiest
03

Conditions

lower urinary tract symptoms (LUTS)

Beyond the preview

Go deeper on NCT06508944.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06508944.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call